MY

Muresh Yadav

Active Director Director DIN 07005276
DIN 07005276 First appointment Nov 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2014
Shareholding value •••• Premium profile

About Muresh Yadav

Data last updated:

Muresh Yadav is a Director at Meritor Pharmaceutical Private Limited (since 2014). The company operates in Pharma. Meritor Pharmaceutical Private Limited reported revenue of ₹5.22 Cr (FY 2025).

DIN 07005276
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2014
Oldest Company Age 11 yrs
Largest company Meritor Pharmaceutical Private Limited · ₹5.22 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20142014₹5.22 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Meritor Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Muresh Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muresh Yadav

Muresh Yadav currently holds 1 directorship: Meritor Pharmaceutical Private Limited (Director, since 21 Nov 2014, revenue ₹5.22 Cr (FY 2025)).

Muresh Yadav was first appointed on 21 Nov 2014 as Director at Meritor Pharmaceutical Private Limited.

The current boards of Muresh Yadav's companies include Dhruvendra Kishor Singh (Meritor Pharmaceutical Private Limited), Durgeshwar Srivastava (Meritor Pharmaceutical Private Limited), Sandeep Kumar Srivastava (Meritor Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available